Envista Holdings Corporation Reports Third Quarter 2026 Financial Results
11/4/2026
Impact: 70
Healthcare
Envista Holdings reported third-quarter 2026 core sales growth of 2.0% in Specialty Products & Technologies and 4.1% in Equipment & Consumables. Adjusted gross margin expanded 20 basis points and adjusted EBITDA margin rose 80 basis points; operating cash flow was $78 million and free cash flow was $63 million. The company repurchased 386,000 shares for approximately $10 million and raised its full-year earnings guidance, citing strong momentum and year-to-date progress.
AI summary, not financial advice
Share: